Frederick Lief Ruberg, MD

Professor, Medicine

Frederick Ruberg
617.638.8968
75 E. Newton St Collamore Building

Biography

Dr. Ruberg’s clinical and research expertise is in the field of cardiac imaging including echocardiography and cardiovascular magnetic resonance imaging (CMR). Dr. Ruberg applies imaging in research designed to facilitate improved diagnosis and management of the infiltrative cardiomyopathy cardiac amyloidosis.

Other Positions

  • Professor, Radiology, Boston University Chobanian & Avedisian School of Medicine
  • Member, Whitaker Cardiovascular Institute, Boston University
  • Member, Amyloidosis Center, Boston University
  • Program Director, Pilot Translational & Clinical Studies Program, Clinical and Translational Science Institute, Boston University Chobanian & Avedisian School of Medicine

Education

  • University of Pennsylvania School of Medicine, MD
  • Haverford College, BA

Publications

  • Published on 10/29/2023

    Stern LK, Grodin JL, Maurer MS, Ruberg FL, Patel AR, Khouri MG, Roth LR, Aras MA, Bhardwaj A, Bhattacharya P, Brailovsky Y, Drachman BM, Ebong IA, Fine NM, Gaggin H, Gopal D, Griffin J, Judge D, Kim P, Mitchell J, Mitter SS, Mohan RC, Ramos H, Reyentovich A, Sheikh FH, Sperry B, Carter S, Urey M, Vaishnav J, Vest AR, Kittleson MM, Patel JK. The Cardiac Amyloidosis Registry Study (CARS): Rationale, Design and Methodology. J Card Fail. 2023 Oct 29. PMID: 37907148.

    Read at: PubMed
  • Published on 10/24/2023

    Gustine JN, Staron A, Mendelson L, Joshi T, Gopal DM, Siddiqi OK, Ruberg FL, Sanchorawala V. Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis. Blood Adv. 2023 Oct 24; 7(20):6080-6091. PMID: 37581513.

    Read at: PubMed
  • Published on 9/14/2023

    Clerc OF, Datar Y, Cuddy SA, Bianchi G, Taylor A, Benz DC, Robertson M, Kijewski MF, Jerosch-Herold M, Kwong RY, Ruberg FL, Liao R, Di Carli MF, Falk RH, Dorbala S. Prognostic Value of Left Ventricular 18 F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis. medRxiv. 2023 Sep 14. PMID: 37745589.

    Read at: PubMed
  • Published on 9/8/2023

    Cochran JD, Yura Y, Thel MC, Doviak H, Polizio AH, Arai Y, Arai Y, Horitani K, Park E, Chavkin NW, Kour A, Sano S, Mahajan N, Evans M, Huba M, Naya NM, Sun H, Ban YH, Hirschi KK, Toldo S, Abbate A, Druley TE, Ruberg FL, Maurer MS, Ezekowitz JA, Dyck JRB, Walsh K. Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction. Circulation. 2023 Oct 10; 148(15):1165-1178. PMID: 37681311.

    Read at: PubMed
  • Published on 7/24/2023

    Madhani A, Sabogal N, Massillon D, Paul LD, Rodriguez C, Fine D, Helmke S, Winburn M, Kurian D, Raiszadeh F, Teruya S, Cohn E, Einstein AJ, Miller EJ, Connors LH, Maurer MS, Ruberg FL. Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study. J Am Heart Assoc. 2023 Aug; 12(15):e028973. PMID: 37486082.

    Read at: PubMed
  • Published on 6/13/2023

    Chan N, Einstein AJ, Griffin JM, Rosenblum H, Teruya S, Cuomo M, De Los Santos J, DeLuca A, Johnson LL, Kinkhabwala MP, Leb JS, Mintz A, Fine D, Helmke S, Muralidhar V, Pandey S, Sabogal N, Saith SE, Winburn M, Smiley D, Miller EJ, Ruberg FL, Maurer MS. Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases. J Nucl Cardiol. 2023 Jun 13. PMID: 37311914.

    Read at: PubMed
  • Published on 5/31/2023

    Ruberg FL. Finally Getting to the Heart of the Matter: Imaging Multiorgan Treatment Response in AL Amyloidosis. JACC Cardiovasc Imaging. 2023 Aug; 16(8):1053-1055. PMID: 37269271.

    Read at: PubMed
  • Published on 4/17/2023

    Ruberg FL, Blaner WS, Chiuzan C, Connors LH, Einstein AJ, Fine D, Helmke S, Kurian D, Pandey S, Raiszadeh F, Rodriguez C, Sabogal N, Teruya S, Winburn M, Chung WK, Cohn E, Miller EJ, Kelly JW, Maurer MS. Design and Rationale the SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study. J Am Heart Assoc. 2023 Apr 18; 12(8):e028534. PMID: 37066788.

    Read at: PubMed
  • Published on 4/13/2023

    Amyar A, Fahmy AS, Guo R, Nakata K, Sai E, Rodriguez J, Cirillo J, Pareek K, Kim J, Judd RM, Ruberg FL, Weinsaft JW, Nezafat R. Scanner-Independent MyoMapNet for Accelerated Cardiac MRI T1 Mapping Across Vendors and Field Strengths. J Magn Reson Imaging. 2023 Apr 13. PMID: 37052580.

    Read at: PubMed
  • Published on 3/30/2023

    Edmiston JB, Cohn EG, Teruya SL, Sabogal N, Massillon D, Muralidhar V, Rodriguez C, Helmke S, Fine D, Winburn M, Chiuzan C, Hod EA, Raiszadeh F, Kurian D, Maurer MS, Ruberg FL. Clinical and social determinants of health features of SARS-CoV-2 infection among Black and Caribbean Hispanic patients with heart failure: The SCAN-MP Study. PLoS One. 2023; 18(3):e0283730. PMID: 36996149.

    Read at: PubMed

View 115 more publications: View full profile at BUMC

View all profiles